68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: Comparison to conventional 51Cr-EDTA

Journal of Nuclear Medicine

Volumn 56, Issue 3, 2015, Pages 405-409

  Hofman, Michael ^a,b   Binns, David ^a   Johnston, Val ^a   Siva, Shankar ^a   Thompson, Mick ^a   Eu, Peter ^a   Collins, Marnie ^a   Hicks, Rodney J ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

51Cr EDTA; 68Ga; EDTA; GFR; Glomerular filtration rate

Indexed keywords

EDETATE CHROMIUM CR 51; GALLIUM EDETATE GA 68; CHROMIUM; CREATININE; EDETIC ACID; GALLIUM; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOGRAPHY; DRUG CLEARANCE; FUNCTIONAL ASSESSMENT; GAMMA COUNTER; GLOMERULUS FILTRATION RATE; HUMAN; IMAGE PROCESSING; KIDNEY FUNCTION; PET-CT SCANNER; PLASMA CLEARANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DETECTOR; RADIATION MEASUREMENT; RADIOISOTOPE DECAY; REFERENCE VALUE; RENOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; URINARY EXCRETION; ALGORITHM; BLADDER; BLOOD; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; FEMALE; KIDNEY; KIDNEY FUNCTION TEST; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; CHROMIUM RADIOISOTOPES; CREATININE; EDETIC ACID; FEMALE; GALLIUM RADIOISOTOPES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER;

EID: 84928155280     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.147843     Document Type: Article

References (33)

1. Millward MJ, Webster LK, Toner GC, et al. Carboplatin dosing based on measurement of renal function: experience at the Peter MacCallum Cancer Institute. Aust N Z J Med. 1996;26:372-379.
2. Shepherd ST, Gillen G, Morrison P, et al. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma. Eur J Cancer. 2014;50:944-952.
3. Craig AJ, Samol J, Heenan SD, Irwin AG, Britten A. Overestimation of carboplatin doses is avoided by radionuclide GFR measurement. Br J Cancer. 2012;107:1310-1316.
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
5. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
6. Hicks RJ, Hofman MS. Is there still a role for SPECT-CT in oncology in the PET-CT era? Nat Rev Clin Oncol. 2012;9:712-720.
7. Yano Y, Anger HOA. Gallium-68 positron cow for medical use. J Nucl Med. 1964;5:484-487.
8. Gleason GI. A positron cow. Int J Appl Radiat Isot. 1960;8:90-94.
9. 68Ga experiences in brain-lesion detection with the positron camera. JAMA. 1966;198:811-813.
10. 55Co-EDTA for renal imaging using positron emission tomography (PET): a feasibility study. Nucl Med Biol. 2000;27:77-81.
11. Aide N, Desmonts C, Beauregard JM, et al. High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications. Eur J Nucl Med Mol Imaging. 2010;37:991-1001.
12. Yamashita M, Inaba T, Kawase Y, et al. Quantitative measurement of renal function using Ga-68-EDTA. Tohoku J Exp Med. 1988;155:207-208.
13. 68Ga for medical application. J Nucl Med. 2007;48:1741-1748.
14. Fleming JS, Zivanovic MA, Blake GM, Burniston M, Cosgriff PS. British Nuclear Medicine Society Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun. 2004;25:759-769.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(327):307-310.
16. 51Cr-edetic-acid complex. Lancet. 1967;1(289):818-819.
17. 51Cr edetic acid, inulin, and endogenous creatinine clearances in 20 patients with renal disease. Br Med J. 1968;1:84-86.
18. 51Cr-EDTA clearance determined by one plasma sample. Clin Physiol. 1981;1:417-425.
19. Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on Renal Clearance. J Nucl Med. 1996;37:1883-1890.
20. Goates JJ, Morton KA, Whooten WW, et al. Comparison of methods for calculating glomerular filtration rate: technetium-99m-DTPA scintigraphic analysis, protein-free and whole-plasma clearance of technetium-99m-DTPA and iodine-125-iothalamate clearance. J Nucl Med. 1990;31:424-429.
21. Mulligan JS, Blue PW, Hasbargen JA. Methods for measuring GFR with technetium-99m-DTPA: an analysis of several common methods. J Nucl Med. 1990;31:1211-1219.
22. HofmanMS, Kong G, Neels OC, Eu P, Hong E, Hicks RJ. High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours. J Med Imaging Radiat Oncol. 2012;56:40-47.
23. Lee JY, Jeong JM, Kim YJ, et al. Preparation of Ga-68-NOTA as a renal PET agent and feasibility tests in mice. Nucl Med Biol. 2014;41:210-215.
24. 51Cr-EDTA. Eur J Nucl Med Mol Imaging. 2003;30:934.
25. 51Cr-EDTA overestimate true renal clearance by 10 percent. Eur J Nucl Med Mol Imaging. 2003;30:4-8.
26. 51Cr-EDTA clearance method for determination of renal function in children and adults. Part II: Empirically determined relationships between total and one-pool clearance. Scand J Clin Lab Invest. 2009;69:314-322.
27. Seo Y, Teo BK, Hadi M, Schreck C, Bacharach SL, Hasegawa BH. Quantitative accuracy of PET/CT for image-based kinetic analysis. Med Phys. 2008;35:3086-3089.
28. Gates GF. Computation of glomerular filtration rate with Tc-99m DTPA: an inhouse computer program. J Nucl Med. 1984;25:613-618.
29. Lopez-Gaitan J, Ebert MA, Robins P, et al. Radiotherapy of abdomen with precise renal assessment with SPECT/CT imaging (RAPRASI): design and methodology of a prospective trial to improve the understanding of kidney radiation dose response. BMC Cancer. 2013;13:381.
30. 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion. Eur J Nucl Med Mol Imaging. 2013;40:1853-1860.
31. O'Reilly P, Aurell M, Britton K, Kletter K, Rosenthal L, Testa T. Consensus on diuresis renography for investigating the dilated upper urinary tract. Radionuclides in Nephrourology Group. Consensus Committee on Diuresis Renography. J Nucl Med. 1996;37:1872-1876.
32. Szabo Z, Xia J, Mathews WB, Brown PR. Future direction of renal positron emission tomography. Semin Nucl Med. 2006;36:36-50.
33. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). Ann ICRP. 1998;28:1-126.